Skip to main content
SpringerLink
Log in

Glycolate oxidase deficiency in a patient with congenital hyperinsulinism and unexplained hyperoxaluria

  • Brief Report
  • Published:
Pediatric Nephrology Aims and scope Submit manuscript

Abstract

Background

A baby girl was born at 39 weeks gestation to consanguineous Asian parents. From day 1 of life she had severe hypoglycaemia with an inappropriately elevated insulin concentration consistent with congenital hyperinsulinism (CHI), confirmed by the finding of a homozygous mutation in ABCC8 (encoding the sulfonylurea receptor 1).

Case diagnosis/Treatment

Urine organic acid analysis showed an incidentally elevated excretion of glycolate. Whilst this was unlikely to contribute to the hypoglycaemia, hyperglycolic aciduria is a known feature of primary hyperoxaluria type 1 (PH1); therefore oxalate was also measured in urine and found to be elevated. Sequence analysis of the genes involved in PH1 and also the two other known forms of primary hyperoxaluria revealed no pathological variants. PH1 was definitively excluded by enzyme activity analysis on a liver biopsy, which confirmed normal glyoxylate aminotransferase (AGT) activity and positive AGT immunoreactivity. Glycolate oxidase (GO) deficiency was considered, and thus gene sequencing of HAO1, which encodes GO, was performed. A homozygous change (c.493G>T p.(Gly165Cys)) was found in exon 3 of HAO1, predicted to be deleterious to protein function. Further analysis of the liver biopsy demonstrated absent GO enzyme activity, confirming GO deficiency in this case.

Conclusions

The results lead to the conclusion that this baby has two unrelated autosomal recessive conditions, CHI and GO deficiency, and also hyperoxaluria of unknown aetiology. Deficiency of GO is a very rare disorder with only two previously published cases. It is considered to be an essentially benign inborn error of metabolism. The present case is unique in that GO deficiency is associated with persistent hyperoxaluria.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Williams E, Cregeen D, Rumsby G (2000) Identification and expression of a cDNA for human glycolate oxidase. Biochim Biophys Acta-Gene Struct Expr 1493:246–248

    Article  CAS  Google Scholar 

  2. Holmes RP, Goodman HO, Hart LJ, Assimos DG (1993) Relationship of protein intake to urinary oxalate and glycolate excretion. Kidney Int 44:366–372

    Article  CAS  PubMed  Google Scholar 

  3. Cochat P, Rumsby G (2013) Primary hyperoxaluria. N Engl J Med 369:649–658

    Article  CAS  PubMed  Google Scholar 

  4. Frishberg Y, Zeharia A, Lyakhovetsky R, Bargal R, Belostotsky R (2014) Mutations in HAO1 encoding glycolate oxidase cause isolated glycolic aciduria. J Med Genet 51:526–529

    Article  CAS  PubMed  Google Scholar 

  5. Liebow A, Li X, Racie T, Hettinger J, Bettencourt BR, Najafian N, Haslett P, Fitzgerald K, Holmes RP, Erbe D, Querbes W, Knight J (2017) An investigational RNAi therapeutic targeting glycolate oxidase reduces oxalate production in models of primary hyperoxaluria. J Am Soc Nephrol 28:494–503

    Article  PubMed  Google Scholar 

  6. Dutta C, Avitahl-Curtis N, Pursell N, Larsson Cohen M, Holmes B, Diwanji R, Zhou W, Apponi L, Koser M, Ying B, Chen D, Shui X, Saxena U, Cyr WA, Shah A, Nazef N, Wang W, Abrams M, Dudek H, Salido E, Brown BD, Lai C (2016) Inhibition of Glycolate oxidase with dicer-substrate siRNA reduces calcium oxalate deposition in a mouse model of primary hyperoxaluria type 1. Mol Ther 24:770–778

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Clifford-Mobley O, Hewitt L, Rumsby G (2016) Simultaneous analysis of urinary metabolites for preliminary identification of primary hyperoxaluria. Ann Clin Biochem 53:485–494

    Article  CAS  PubMed  Google Scholar 

  8. Rumsby G, Weir T, Samuell CT (1997) A Semiautomated alanine: Glyoxylate aminotransferase assay for the tissue diagnosis of primary Hyperoxaluria type 1. Ann Clin Biochem 34:400–404

    Article  CAS  PubMed  Google Scholar 

  9. Williams EL (2003) Human liver glycolate oxidase gene identification and protein studies. PhD thesis. University College London, London

  10. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193:265–275

    CAS  PubMed  Google Scholar 

  11. Williams E, Rumsby G (2007) Selected exonic sequencing of the AGXT gene provides a genetic diagnosis in 50% of patients with primary hyperoxaluria type 1. Clin Chem 53:1216–1221

    Article  CAS  PubMed  Google Scholar 

  12. Schwarz JM, Cooper DN, Schuelke M, Seelow D (2014) MutationTaster2: mutation prediction for the deep-sequencing age. Nat Methods 11:361–362

    Article  CAS  PubMed  Google Scholar 

  13. Ng PC, Henikoff S (2003) SIFT: predicting amino acid changes that affect protein function. Nucleic Acids Res 31:3812–3814

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Adzhubei IA, Schmidt S, Peshkin L, Ramensky VE, Gerasimova A, Bork P, Kondrashov AS, Sunyaev SR (2010) A method and server for predicting damaging missense mutations. Nat Methods 7:248–249

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. Narasimhan VM, Hunt KA, Mason D, Baker CL, Karczewski KJ, Barnes MR, Barnett AH, Bates C, Bellary S, Bockett NA, Giorda K0, Griffiths C, Hemingway H, Jia Z, Kelly MA, Khawaja H, Lek M, McCarthy S, McEachan R, O’Donnell-Luria A, Paigen K, Parisinos CA, Sheridan E, Southgate L, Tee L, Thomas M, Xue Y, Schnall-Levin M, Petkov PM, Tyler-Smith C, Maher ER, Trembath RC, DG MA, Wright J, Durbin R, van Heel DA (2016) Health and population effects of rare gene knockouts in adult humans with related parents. Science 352:474–477

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. Murray MS, Holmes RP, Lowther WT (2008) Active site and loop 4 movements within human glycolate oxidase: implications for substrate specificity and drug design. Biochemistry 47:2439–2449

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  17. Thomas PM, Cote GJ, Wohllk N, Haddad B, Mathew PM, Rabl W, Aguilar-Bryan L, Gagel RF, Bryan J (1995) Mutations in the sulfonylurea receptor gene in familial persistent hyperinsulinemic hypoglycemia of infancy. Science 268:426–429

    Article  CAS  PubMed  Google Scholar 

  18. Yorifuji T (2014) Congenital hyperinsulinism: current status and future perspectives. Ann Pediatr Endocrinol Metab 19:57–68

    Article  PubMed  PubMed Central  Google Scholar 

  19. Senniappan S, Shanti B, James C, Hussain K (2012) Hyperinsulinaemic hypoglycaemia: genetic mechanisms, diagnosis and management. J Inherit Metab Dis 35:589–601

    Article  CAS  PubMed  Google Scholar 

  20. Senniappan S, Alexandrescu S, Tatevian N, Shah P, Arya V, Flanagan S, Ellard S, Rampling D, Ashworth M, Brown RE, Hussain K (2014) Sirolimus therapy in infants with severe hyperinsulinemic hypoglycemia. N Engl J Med 370:1131–1137

    Article  CAS  PubMed  Google Scholar 

  21. Martin-Higueras C, Luis-Lima S, Salido E (2016) Glycolate oxidase is a safe and efficient target for substrate reduction therapy in a mouse model of primary hyperoxaluria type I. Mol Ther 24:719–725

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  22. Clifford-Mobley O, Tims C, Rumsby G (2015) The comparability of oxalate excretion and oxalate:creatinine ratio in the investigation of primary hyperoxaluria: review of data from a referral centre. Ann Clin Biochem 52:113–121

    Article  CAS  PubMed  Google Scholar 

  23. Van Schaftingen E, Draye J-P, Van Hoof F (1989) Coenzyme specificity of mammalian liver d-glycerate dehydrogenase. Eur J Biochem 186:355–359

    Article  PubMed  Google Scholar 

  24. Poore RE, Hurst CH, Assimos DG, Holmes RP (1997) Pathways of hepatic oxalate synthesis and their regulation. Am J Phys 272:C289–C294

    CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Clinical Biochemistry, Bristol Royal Infirmary, University Hospitals Bristol NHS Foundation Trust, Bristol, BS2 8HW, UK

    Oliver Clifford-Mobley

  2. University College London Hospitals NHS Foundation Trust, London, UK

    Gill Rumsby

  3. Alder Hey Children’s Hospital NHS Foundation Trust, Liverpool, UK

    Swati Kanodia, Mohammed Didi, Richard Holt & Senthil Senniappan

Authors
  1. Oliver Clifford-Mobley
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Gill Rumsby
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Swati Kanodia
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Mohammed Didi
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Richard Holt
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Senthil Senniappan
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Oliver Clifford-Mobley.

Ethics declarations

Conflict of interest

The authors declare that they have no conflicts of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Clifford-Mobley, O., Rumsby, G., Kanodia, S. et al. Glycolate oxidase deficiency in a patient with congenital hyperinsulinism and unexplained hyperoxaluria. Pediatr Nephrol 32, 2159–2163 (2017). https://doi.org/10.1007/s00467-017-3741-1

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00467-017-3741-1

Keywords

Search

Navigation